Abstract
All cancers arise as a result of abnormalities occurring in the DNA sequence of cancer cells, and we are now stepping into an era in which it is feasible to obtain the complete DNA sequence of large cohorts of cancer patients. The International Cancer Genome Consortium (ICGC) launched in 2007 is devoted to coordinate large-scale cancer genome studies in tumors from 50 different cancer types and/or subtypes and systematic studies of more than 25,000 cancer genomes. Several participant groups have summarized and published their data for various cancers. As the active members of ICGC, Chinese cancer genome investigators have contributed research for 13 tumor types and released some research articles about esophageal, liver, bladder, and kidney cancers. As genetic alterations in thousands of tumors have now been catalogued, the pan-cancer analysis has become the most significant role of ICGC at present. The ICGC research network will reveal the repertoire of oncogenic mutations, uncover traces of the mutagenic influences, define molecular subtypes for clinical implication, and enable the development of individual therapeutics for human cancers.
Similar content being viewed by others
Reference
Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674
Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70
Dulbecco R (1986) A turning point in cancer research: sequencing the human genome. Science 231:1055–1056
Venter JC, Adams MD, Myers EW et al (2001) The sequence of the human genome. Science 291:1304–1351
Lander ES, Linton LM, Birren B et al (2001) Initial sequencing and analysis of the human genome. Nature 409:860–921
International Human Genome Sequencing C (2004) Finishing the euchromatic sequence of the human genome. Nature 431:931–945
International Cancer Genome C (2010) International network of cancer genome projects. Nature 464:993–998
Toronto International Data Release Workshop A (2009) Prepublication data sharing. Nature 461:168–170
Alexandrov LB, Nik-Zainal S, Wedge DC et al (2013) Signatures of mutational processes in human cancer. Nature 500:415–421
Nik-Zainal S, Van Loo P, Wedge DC et al (2012) The life history of 21 breast cancers. Cell 149:994–1007
Papaemmanuil E, Cazzola M, Boultwood J et al (2011) Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts. N Engl J Med 365:1384–1395
Malcovati L, Papaemmanuil E, Bowen DT et al (2011) Clinical significance of SF3B1 mutations in myelodysplastic syndromes and myelodysplastic/myeloproliferative neoplasms. Blood 118:6239–6246
Papaemmanuil E, Gerstung M, Malcovati L et al (2013) Clinical and biological implications of driver mutations in myelodysplastic syndromes. Blood 122:3616–3627 quiz 3699
India Project Team of the International Cancer Genome C (2013) Mutational landscape of gingivo-buccal oral squamous cell carcinoma reveals new recurrently-mutated genes and molecular subgroups. Nat Commun 4:2873
Jones DT, Hutter B, Jager N et al (2013) Recurrent somatic alterations of FGFR1 and NTRK2 in pilocytic astrocytoma. Nat Genet 45:927–932
Tirode F, Surdez D, Ma X et al (2014) Genomic landscape of Ewing sarcoma defines an aggressive subtype with co-association of STAG2 and TP53 mutations. Cancer Discov 4:1342–1353
Dove ES, Joly Y, Tasse AM et al (2014) Genomic cloud computing: legal and ethical points to consider. Eur J Hum Genet. doi:10.1038/ejhg.2014.196
Gonzalez-Perez A, Mustonen V, Reva B et al (2013) Computational approaches to identify functional genetic variants in cancer genomes. Nat Methods 10:723–729
Wong CC, Martincorena I, Rust AG et al (2014) Inactivating CUX1 mutations promote tumorigenesis. Nat Genet 46:33–38
Yan XJ, Xu J, Gu ZH et al (2011) Exome sequencing identifies somatic mutations of DNA methyltransferase gene DNMT3A in acute monocytic leukemia. Nat Genet 43:309–315
Cao Y, Gao Z, Li L et al (2013) Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1. Nat Commun 4:2810
Cao Y, He M, Gao Z et al (2014) Activating hotspot L205R mutation in PRKACA and adrenal Cushing’s syndrome. Science 344:913–917
Guo G, Sun X, Chen C et al (2013) Whole-genome and whole-exome sequencing of bladder cancer identifies frequent alterations in genes involved in sister chromatid cohesion and segregation. Nat Genet 45:1459–1463
Gui Y, Guo G, Huang Y et al (2011) Frequent mutations of chromatin remodeling genes in transitional cell carcinoma of the bladder. Nat Genet 43:875–878
Guo G, Gui Y, Gao S et al (2012) Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma. Nat Genet 44:17–19
Lin DC, Hao JJ, Nagata Y et al (2014) Genomic and molecular characterization of esophageal squamous cell carcinoma. Nat Genet 46:467–473
Song Y, Li L, Ou Y et al (2014) Identification of genomic alterations in oesophageal squamous cell cancer. Nature 509:91–95
Gao YB, Chen ZL, Li JG et al (2014) Genetic landscape of esophageal squamous cell carcinoma. Nat Genet 46:1097–1102
Huang J, Deng Q, Wang Q et al (2012) Exome sequencing of hepatitis B virus-associated hepatocellular carcinoma. Nat Genet 44:1117–1121
Li M, Zhao H, Zhang X et al (2011) Inactivating mutations of the chromatin remodeling gene ARID2 in hepatocellular carcinoma. Nat Genet 43:828–829
Kan Z, Zheng H, Liu X et al (2013) Whole-genome sequencing identifies recurrent mutations in hepatocellular carcinoma. Genome Res 23:1422–1433
Sung WK, Zheng H, Li S et al (2012) Genome-wide survey of recurrent HBV integration in hepatocellular carcinoma. Nat Genet 44:765–769
Tao Y, Ruan J, Yeh SH et al (2011) Rapid growth of a hepatocellular carcinoma and the driving mutations revealed by cell-population genetic analysis of whole-genome data. Proc Natl Acad Sci USA 108:12042–12047
Zong C, Lu S, Chapman AR et al (2012) Genome-wide detection of single-nucleotide and copy-number variations of a single human cell. Science 338:1622–1626
Ni X, Zhuo M, Su Z et al (2013) Reproducible copy number variation patterns among single circulating tumor cells of lung cancer patients. Proc Natl Acad Sci USA 110:21083–21088
Hou Y, Song L, Zhu P et al (2012) Single-cell exome sequencing and monoclonal evolution of a JAK2-negative myeloproliferative neoplasm. Cell 148:873–885
Li Y, Xu X, Song L et al (2012) Single-cell sequencing analysis characterizes common and cell-lineage-specific mutations in a muscle-invasive bladder cancer. GigaScience 1:12
Xu X, Hou Y, Yin X et al (2012) Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148:886–895
Yu C, Yu J, Yao X et al (2014) Discovery of biclonal origin and a novel oncogene SLC12A5 in colon cancer by single-cell sequencing. Cell Res 24:701–712
Acknowledgment
This work was supported by the National Natural Science Foundation of China (81402300). We thank Scott Edmunds for revising this manuscript.
Conflict of interest
The authors declare that they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Hu, X., Yang, H., He, J. et al. The cancer genomics and global cancer genome collaboration. Sci. Bull. 60, 65–70 (2015). https://doi.org/10.1007/s11434-014-0692-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11434-014-0692-9